IlluminOss Medical to Showcase World's First Minimally Invasive Conforming Implant System at AAOS 2015
(firmenpresse) - EAST PROVIDENCE, RI -- (Marketwired) -- 03/17/15 --
, a privately-held, commercial stage medical device company focused on minimally invasive orthopedic fracture repair. The IlluminOss System is the world's first and only system of its kind and offers significant advantages for the treatment of complex fractures.
IlluminOss Medical will be exhibiting its technology at . The utilizes a light-curable polymer, contained within an expandable balloon catheter, to achieve bone stabilization. The simple, percutaneous surgical approach enables surgeons to create a patient-conforming implant. In many cases it allows the patient to get back to daily activities more quickly without the hindrance of a hard cast.
observed from the use of the product in patients include smaller incisions, shorter procedure times, and more rapid post-procedure patient mobility with reduced hospital stays and lower complication rates. The small diameter of the flexible catheter gives the surgeon greater freedom of surgical approach. Once cured, the implant provides longitudinal strength and rotational stability over the length of the implant.
Venetian/Sands Expo
Las Vegas, NV
March 24-28, 2015
IlluminOss Medical is a privately-held, commercial stage medical device company focused on designing, developing and marketing orthopedic fracture repair products that leverage its proprietary bone stabilization technology, the IlluminOss System. This minimally invasive technology allows for fracture fixation through patient specific intramedullary implants. The system utilizes a light-curable polymer, contained within an expandable balloon catheter, to achieve bone stabilization. The revolutionary procedure is made through a small percutaneous surgical approach providing patients and clinicians with a fast, patient-specific, method of orthopedic bone stabilization. The company currently markets its products in international countries under a CE Mark for approved clinical applications through both a direct sales force and distribution networks.
Founded in 2007, IlluminOss is headquartered in East Providence, RI, and funded by Foundation Medical Partners, New Leaf Venture Partners, Tekla Capital, Life Sciences Partners, SR One, Longwood Fund, Excel Venture Management, Pappas Ventures, Mieza Capital and Slater Technology. Learn more at .
The IlluminOss products are Investigational Devices; limited by Federal law to Investigational Use and are not approved for sale in the USA.
Jordan Bouclin
SVM Public Relations
(401)490-9700
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 17.03.2015 - 14:08 Uhr
Sprache: Deutsch
News-ID 379108
Anzahl Zeichen: 0
contact information:
Town:
EAST PROVIDENCE, RI
Kategorie:
Hospitals, Facilities and Providers
Diese Pressemitteilung wurde bisher 313 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"IlluminOss Medical to Showcase World's First Minimally Invasive Conforming Implant System at AAOS 2015"
steht unter der journalistisch-redaktionellen Verantwortung von
IlluminOss Medical (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
